Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: From experimental discovery to validation in two independent patient cohorts
Richard C. Lauer, Marc Barry, Tracey L. Smith, View ORCID ProfileAndrew Maltez Thomas, Jin Wu, Ruofei Du, View ORCID ProfileJi-Hyun Lee, Arpit Rao, Andrey S. Dobroff, Marco A. Arap, Diana N. Nunes, Israel T. Silva, Emmanuel Dias-Neto, Isan Chen, Dennis J. McCance, Webster K. Cavenee, Renata Pasqualini, View ORCID ProfileWadih Arap
doi: https://doi.org/10.1101/2022.10.25.22281522
Richard C. Lauer
1University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, USA
2Division of Hematology/Oncology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA
Marc Barry
3Department of Pathology, University of Utah, Salt Lake City, Utah, USA
Tracey L. Smith
4Rutgers Cancer Institute of New Jersey, Newark, New Jersey, USA
5Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, New Jersey, USA
Andrew Maltez Thomas
6Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, SP, Brazil
15Laboratory of Medical Genomics, A.C. Camargo Cancer Center, São Paulo, São Paulo, Brazil
Jin Wu
1University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, USA
7Department of Pathology, University of New Mexico, Albuquerque, New Mexico, USA
Ruofei Du
8Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
Ji-Hyun Lee
9Department of Biostatistics, University of Florida, Gainesville, Florida, USA
10Division of Quantitative Sciences, University of Florida Health Cancer Center, Gainesville, Florida, USA
Arpit Rao
11Section of Hematology and Oncology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
Andrey S. Dobroff
1University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, USA
12Division of Molecular Medicine, Department of Medicine, Albuquerque, New Mexico, USA
Marco A. Arap
13Division of Urology, University of São Paulo Medical School, São Paulo, Brazil
14Syrian-Lebanese Hospital, São Paulo, São Paulo, Brazil
Diana N. Nunes
15Laboratory of Medical Genomics, A.C. Camargo Cancer Center, São Paulo, São Paulo, Brazil
Israel T. Silva
16Laboratory of Bioinformatics and Computational Biology, A.C. Camargo Cancer Center, São Paulo, São Paulo, Brazil
Emmanuel Dias-Neto
15Laboratory of Medical Genomics, A.C. Camargo Cancer Center, São Paulo, São Paulo, Brazil
Isan Chen
17MBrace Therapeutics, San Diego, California, USA
Dennis J. McCance
1University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, USA
7Department of Pathology, University of New Mexico, Albuquerque, New Mexico, USA
Webster K. Cavenee
18Ludwig Institute for Cancer Research, University of California-San Diego, La Jolla, California, USA
Renata Pasqualini
4Rutgers Cancer Institute of New Jersey, Newark, New Jersey, USA
5Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, New Jersey, USA
Wadih Arap
4Rutgers Cancer Institute of New Jersey, Newark, New Jersey, USA
19Division of Hematology/Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA
Article usage
Posted October 30, 2022.
Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: From experimental discovery to validation in two independent patient cohorts
Richard C. Lauer, Marc Barry, Tracey L. Smith, Andrew Maltez Thomas, Jin Wu, Ruofei Du, Ji-Hyun Lee, Arpit Rao, Andrey S. Dobroff, Marco A. Arap, Diana N. Nunes, Israel T. Silva, Emmanuel Dias-Neto, Isan Chen, Dennis J. McCance, Webster K. Cavenee, Renata Pasqualini, Wadih Arap
medRxiv 2022.10.25.22281522; doi: https://doi.org/10.1101/2022.10.25.22281522
Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: From experimental discovery to validation in two independent patient cohorts
Richard C. Lauer, Marc Barry, Tracey L. Smith, Andrew Maltez Thomas, Jin Wu, Ruofei Du, Ji-Hyun Lee, Arpit Rao, Andrey S. Dobroff, Marco A. Arap, Diana N. Nunes, Israel T. Silva, Emmanuel Dias-Neto, Isan Chen, Dennis J. McCance, Webster K. Cavenee, Renata Pasqualini, Wadih Arap
medRxiv 2022.10.25.22281522; doi: https://doi.org/10.1101/2022.10.25.22281522
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12609)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4479)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1058)
- Hematology (378)
- HIV/AIDS (908)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4240)
- Nursing (227)
- Nutrition (620)
- Oncology (2223)
- Ophthalmology (631)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (486)
- Public and Global Health (6826)
- Radiology and Imaging (1502)
- Respiratory Medicine (908)
- Rheumatology (430)
- Sports Medicine (374)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)